Christophe Mossé appointed as CEO of Arkopharma group

christophe mossé arkopharma

Key Points

  • Christophe Mossé appointed as CEO of Arkopharma group
  • He will oversee Arkopharma’s activities and related activities of Dermapharm Group.
  • Brings industry expertise from leading groups: Naos, Galderma, Novartis,…

Founded in 1980 in Carros, near Nice, Arkopharma is a pharmaceutical laboratory specialized in phytotherapy, natural medicines, and dietary supplements.

Arkopharma, a European leader in its field, has announced the arrival of Christophe Mossé as CEO (cf. LinkedIn post below)

Christophe Mossé brings a wealth of experience in the pharmaceutical industry, both in France and internationally.

With his expertise, Christophe Mossé will lead Arkopharma’s activities and related operations of Dermapharm Group, and will be the main link between the management teams of the two entities.

Arkopharma is now present in more than 60 countries and is positioned as the European leader in phytotherapy medicines and dietary supplements.

With 1,212 employees and a consolidated turnover of 201 million euros, Arkopharma dedicates 8.5% of its workforce to research and development, with 1,635 registrations and marketing authorizations for medicines.

Health Nice Côte d’Azur

Share it :

our events


10 July 2024
Nice met l’océan au sommet jusqu’au 10 juillet
Journée de l'ocean
21 July 2024
Arrivée du Tour de France 2024
Tour de france 2024
Palais de la Méditerranée - Nice
26 September 2024
Nice Climate Summit
Allianz Riviera
15 October 2024
IBT 2024 : le rdv de l’industrie et de la construction
IBT 2024
5 June 2025
Conférence des Nations Unies sur les Océans
Conférence sur les Océans - Nations Unies

Restons En Contact

Inscrivez Vous À Notre Newsletter

Keep in touch

Subscribe to our newsletter

Make an appointment

Leave us your contact details
to schedule a meeting with one of our experts.